![]() |
|
|
4 Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724 and 5 Arizona Cancer Center, Tucson, AZ 85724
* To whom correspondence should be addressed. E-mail: ihakim{at}email.arizona.edu.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although direct evidence that links 8-OHdG with cancer risk is lacking, increased 8-OHdG has been found in different cancerous tissues (2). Moreover, urinary 8-OHdG was higher in small-cell lung carcinoma patients than in normal controls (3). A link between 8-OHdG formation and tobacco smoke carcinogenesis has been suggested by the fact that increased 8-OHdG levels were observed in lung DNA (4), peripheral leukocyte DNA (5), and the nuclei of oral mucosa (6) from smokers as compared with nonsmokers. In addition, a 50% increase in the levels of 8-OHdG was detected in the urine of smokers as compared with the urine of nonsmokers (7). Together, these data strongly implicate 8-OHdG formation in tobacco smoke-induced carcinogenic pathways.
Genetic susceptibility to environmental carcinogens, such as tobacco smoke, is thought to be attributable to genetic polymorphisms in metabolizing enzymes, which substantially alter the activation and elimination of carcinogens (8,9). Glutathione S-transferase (GST), a member of the phase II group of xenobiotic metabolizing enzymes, has been intensively studied at the levels of phenotype and genotype. Up to 50% of whites have no GSTM1 enzyme because of the homozygous deletion of the gene (10,11), referred to as the GSTM1 null genotype. The GSTM1 null genotype is found in
50% of Europeans, Japanese, and white Americans but in only one-quarter of Afro-Americans (12). Lack of M1 enzyme may result in deficient detoxification of tobacco smoke carcinogens leading to a slight increase in the risk of lung cancer (13,14). Similarly, genetic background has been demonstrated to be involved in the control of damaged DNA repair. The human OGG1 (hOGG1) gene encodes a DNA glycosylase/AP-lyase that is involved in the excision repair of 8-OHdG from oxidatively damaged DNA (15,16). Previous studies have revealed the presence of several polymorphisms at the hOGG1 locus. A C/G polymorphism at position 1245 in the 1-specific exon 7 of the hOGG1 gene results in an amino acid substitution from serine to cysteine in codon 326 (17). The hOGG1 protein encoded by the wild-type Ser326 allele exhibited substantially higher DNA repair activity than the Cys326 variant in an in vitro Escherichia coli complementation activity assay (17). Although no association between the Cys326 and Ser326 variants and breast cancer risk were observed in 2 recent breast cancer case-control studies (18,19), other studies have suggested that the Ser326Cys hOGG1 polymorphism may be associated with increased risk for lung (20) as well as esophageal (21) cancer. Significant increases in orolaryngeal cancer risk were observed for both the hOGG1 Ser326/Cys326 heterozygote and the hOGG1 Cys326/Cys326 homozygote (22).
Changes in dietary habits with the intake of more cancer-chemopreventive agents appear to be a practical approach for cancer prevention in subjects with increased oxidative stress, as is the case of smokers. People have been brewing tea made from the leaves of the Camellia sinensis plant for almost 50 centuries. Tea polyphenols scavenge active oxygen radicals (23) and inhibit DNA biosynthesis of the tumor cells (24) and chemocarcinogen-induced carcinogenesis (25). Tea can be easily consumed with one's ordinary meals, making compliance and adherence to dietary intervention more likely to succeed. Thus, the role of tea drinking as a potential inhibitor of carcinogenesis merits careful evaluation. We have previously shown that although there was no important interaction among smoking, hOGG1 genotypes, and green tea intake in terms of levels of urinary 8-OHdG (26), smokers with GSTM1 null genotypes were less likely to benefit from a green tea intervention (27).
We were interested in whether there were differences in increased oxidative stress susceptibility to smoking within the combined GSTM1 and hOGG1 genotypes and the impact of green tea drinking on this. Because both GSTM1 and OGG1 polymorphisms occur at reasonable frequencies, statistically meaningful conclusions can be drawn from studies of relatively small numbers of subjects.
| Materials and Methods |
|---|
|
|
|---|
Urinary 8-OHdG was measured by an ELISA kit, the validity and comparability of which to high-performance liquid chromatography with electrochemical detection had already been verified (29,30). First void urine samples were typically assayed in triplicate. The intra-assay coefficient of variation of this assay was 4.9%. Data were corrected by urinary creatinine concentration and expressed as nanograms 8-OHdG/mg creatinine.
Urinary creatinine levels were determined using a creatinine assay kit (31) with an intra-assay coefficient of variation of 3.6%. Total catechins in plasma were determined spectrophotometrically (32,33).
To assess individual GSTM1 genotypes (34) and the hOGG1 Ser326Cys polymorphism in exon 7 (35), DNA was extracted from whole blood and analyzed by polymerase chain reaction.
Statistical methods. All statistical analyses were performed using Stata Statistical Software (Intercooled stata 7; StataCorp). Multiple linear regression models were used to estimate the main effects of green and black tea intake on creatinine-adjusted urinary 8-OHdG, with or without adjustment for potential confounders. Potential confounders considered were baseline levels of creatinine-adjusted urinary 8-OHdG, BMI, percentage body fat, amount of beverage consumed, cohort effect, physical activity, and antioxidants. Finally, we studied whether the effect of treatment varied by GSTM1 and hOGG1 status of the individual. Statistical tests were 2-sided with a significance level of 0.05.
| Results |
|---|
|
|
|---|
|
|
The results of the final model for the 2 tea interventions, adjusted for baseline 8-OHdG levels, BMI, percentage body fat, amount of beverage consumed, cohort effect, and physical activity, showed a highly significant decrease in urinary 8-OHdG (–31%) after 4 mo of drinking decaffeinated green tea (P = 0.001). The change from baseline was significant in the GSTM1-positive green tea group (P = 0.006) but not in the GSTM1-negative green tea group (P = 0.07). We found no important interaction among smoking, hOGG1 genotypes, and tea intervention in terms of levels of urinary 8-OHdG (Table 2).
We then looked at smokers with combined GSTM1 and hOGG1 genotypes. Our data show that changes in urinary 8-OHdG from baseline were significant in GSTM1-positive green tea group smokers regardless of their hOGG1 genotype. No major effects were seen in smokers with the GSTM1 null genotypes regardless of their hOGG1 genotype.
| Discussion |
|---|
|
|
|---|
Individuals lacking GSTM1 are thought to have impaired ability to eliminate carcinogens and therefore to be at increased cancer risk (37). The effect of this polymorphism was greater among heavy smokers (38). Although several epidemiological studies have found the null genotype to be associated with increased risk for the development of lung and other tobacco-related cancers (38–40), the findings in other studies are conflicting, and this association remains controversial (41–43). In our study, we used urinary 8-OHdG to determine the efficacy of regular tea drinking in decreasing the carcinogenic effects of cigarette smoking. We have previously reported a greater effect of green tea consumption on urinary 8-OHdG levels among GSTM1-positive than among GSTM1-negative subjects; that is, the change from baseline was significant in the GSTM1-positive green tea group but not in the GSTM1-negative green tea group (26).
There are several studies implicating oxidative stress and subsequent 8-OHdG formation in human lung carcinogenesis (3,44,45). The levels of 8-OHdG measured at any time represent the integration of a number of parameters, including reactive oxygen species production, cellular redox status, and antioxidant defense mechanisms, as well as DNA repair systems. Therefore, the interindividual differences in repairing these lesions may be associated with lung cancer susceptibility. Although several epidemiological studies have found the Cys/Cys genotype to be associated with increased risk for the development of lung and other tobacco-related cancers, these findings, especially in relation to the Ser/Cys genotype, are conflicting, and this association remains controversial (18–21,46,47). The Ser326Cys substitution polymorphism in the hOGG1 gene has been suggested, based on in vitro data, to reduce the activity of the enzyme. However, 8-OHdG levels in nuclear DNA were similar among lung cancer cells and leukocytes irrespective of the type of hOGG1 proteins expressed suggesting that 8-OHdG levels are maintained at a steady level, even though multiple hOGG1 proteins are produced as a result of genetic polymorphisms (17). In our study, the homozygous Cys/Cys genotype was present in only 10% of our study population. Therefore, the mutant types (Ser/Cys and Cys/Cys) were combined and compared with the Ser/Ser genotype. However, we should be aware that there is no solid biological rationale for the combination of Ser/Cys plus Cys/Cys as 1 group at this moment. We reported that smokers in the green tea group experienced a significant decrease in urinary 8-OHdG levels regardless of their hOGG1 genotypes (27).
Because of the complexity of cancer etiology, it is unlikely that a single polymorphism, either GSTM1 null or hOGG1 Cys/Cys plus Ser/Cys could explain most cancer susceptibility. The joint analysis of several metabolic gene polymorphisms implied in carcinogen activation, detoxification, and repair may provide new clues. Because the numbers of smokers in this study were reasonably large, the numbers in individual genotype classes were sufficient to examine the effects of combination of genotypes, for instance, to see the effects of green tea drinking on smokers who are both GSTM1 null and hOGG1 Cys/Cys plus Ser/Cys. Our data show that changes in urinary 8-OHdG from baseline were significant only in the GSTM1-positive green tea group smokers regardless of their hOGG1 genotype. Smoking behavior and levels of dietary and plasma antioxidants did not change in any group during study participation, indicating that changes in smoking behavior and/or diet are not responsible for the observed decrease in DNA damage.
In this randomized, controlled trial of smoking adults, daily drinking of 4 cups (960 mL) of decaffeinated green tea was associated with a significant decrease in urinary excretion of 8-OHdG among GSTM1-positive smokers regardless of their hOGG1 genotype. It is not known why decaffeinated green tea intervention resulted in a reduction in overall oxidative damage in GSTM1-positive smokers regardless of their hOGG1 genotype. Induction of phase II enzymes including GST has been postulated as 1 of the mechanisms responsible for the anticarcinogenic effect of green tea. Therefore, induction of GST enzyme activities may be more prominent in GSTM1-positive individuals. Moreover, Hardie et al. (48) reported that 8-OHdG levels in normal lung tissue DNA were not associated with constitutive hOGG1 genotype and that 8-OHdG levels in nuclear DNA were similar among lung cancer cells and leukocytes irrespective of the type of hOGG1 proteins expressed (17). This study shows that hOGG1 genotypes have no effect on the 8-OHdG levels in leukocytes and lung tissues, suggesting that the 8-OHdG levels are not dependent on the activity of this repair protein. This is consistent with our observations that green tea intervention effect on 8-OHdG levels is not modulated by hOGG1 genotypes.
Our data suggest that GSTM1 genotype may play a more important role in relation to DNA damage as compared with hOGG1 genotype. Further studies are necessary to understand the interaction among green tea consumption, GST genotypes, and hOGG1 genotypes in relation to smoking-induced oxidative DNA damage.
Some limitations of this present study should be noted. One potential limitation was that the study subjects were not unaware of the beverage they were consuming. It was necessary to use commercially available products because we were mainly interested in studying the effect of regular consumption of decaffeinated green and black tea in the forms in which they are commonly consumed. However, all the tea used in the trial was obtained from the same supplier, and tea content analyses were performed for each cohort to ensure standardization of product. Data from the self-reported diaries and recalls suggest high adherence with no use of other tea products to supplement the intervention. This high adherence to all regimens suggests that any bias based on prior beliefs of the intervention is reduced. There have been concerns raised about the validity of methods used to measure 8-OHdG (49). Nevertheless, even with the variation in methods, the creatinine-standardized concentrations of 8-OHdG seem broadly similar among different laboratories (50). Furthermore, the 4.9% intra-assay coefficient of variation we found in this study suggests satisfactory repeatability of the ELISA.
In conclusion, in this randomized controlled trial, drinking 4 cups (960 mL) of decaffeinated green tea daily for 4 mo was associated with statistically significant decrease in urinary 8-OHdG among GSTM1-positive heavy smokers regardless of their hOGG1 genotypes.
Other articles in this supplement include references (51–60).
| FOOTNOTES |
|---|
2 Author disclosures: I. A. Hakim, H.-H. S. Chow, and R. B. Harris, no conflicts of interest. ![]()
3 This research was supported by a grant (ID 10005) from the Arizona Disease Control Research Commission. The decaffeinated tea used in the study was kindly supplied by Unilever Bestfoods North America, NJ, USA. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA. 1989;86:9697–701.
2. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer. 1996;32A:1209–14.
3. Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 1997;409:287–91.[Medline]
4. Kim KB, Lee BM. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo[a]pyrene. Cancer Lett. 1997;113:205–12.[Medline]
5. Lodovici M, Casalini C, Cariaggi R, Michelucci L, Dolara P. Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic Biol Med. 2000;28:13–7.[Medline]
6. Romano G, Sgambato A, Flamini G, Boninsegna A, Milito S, Ardito R, Cittadini A. Evaluation of 8-hydrodeoxyguanosine in human oral cells: the importance of tobacco smoke and urban environment. Anticancer Res. 2000;20:3801–5.[Medline]
7. Loft S, Vistisen K, Ewertz M, Jonneland AT, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxy-deoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13:2241–7.
8. Smith CAD, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer. 1994;30A:1921–35.
9. Gonzalez FJ, Idle JR. Pharmacogenetic phenotyping and genotyping: present status and future potential. Clin Pharmacokinet. 1994;26:59–70.[Medline]
10. Seidegard J, Pero R. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet. 1985;69:66–8.[Medline]
11. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on transtilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 1988;85:7293–7.
12. Dusinská M, Ficek A, Horská A, Raslová K, Petrovská H, Vallová B, Drlicková M, Wood SG, Stupáková A, et al. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res. 2001;482:47–55.[Medline]
13. Soni M, Madurantakan M, Krishnaswamy K. Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology. 1998;126:155–62.[Medline]
14. d'Errico A, Malats N, Vineis P, Boffetta P. Review of studies of selected metabolic polymorphisms and cancer. IARC Sci Publ. 1999;148:323–93.[Medline]
15. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377:1–82.[Medline]
16. Sunaga N, Khono T, Shinmura K, Saitoh T, Matsuda T, Saito R, Yokota J. OGGI protein suppresses G:CT:A mutation in a shuttle vector containing 8-hydroxyguanine in human cells. Carcinogenesis. 2001;22:1355–62.
17. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–25.[Medline]
18. Vogel U, Nexo A, Olsen A, Thomsen B, Jacobsen NR, Wallin H, Overvad K, Tjonneland A. No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:170–1.
19. Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, et al. hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res Treat. 2003;79:59–62.[Medline]
20. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1999;8:669–74.
21. Xing D-Y, Tan W, Song N, Lin D-X. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer. 2001;95:140–3.[Medline]
22. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 2002;23:1229–34.
23. Cheng S, Ding L, Zhen Y, Lin P, Zhu Y, Chen Y, Hu X. Progress in studies on the antimutagenicity and anticarcinogenicity of green tea epicatechins. Chinese Medical Sciences Journal. 1991;6:233–8.[Medline]
24. Katiyar SK, Agarwal R, Wang ZY. (–)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of bikkim inhibitory effects against biochemical events and tumor initiation in sencar mouse skin. Nutr Cancer. 1992;18:73–83.[Medline]
25. Xu GP, Song PJ, Reed PI. Effects of fruit juices, processed vegetable juice, orange peel and green tea on endogenous formation of N-nitrosoproline in subjects from a high-risk area for gastric cancer in Moping County, China. European Journal of Cancer Prevention. 1993;2:327–35.[Medline]
26. Hakim IA, Harris RB, Chow H-HS, Dean M, Brown S, Ali IU. Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of GST genotypes. Cancer Epidemiol Biomarkers Prev. 2004;13:242–9.
27. Hakim IA, Chow H-HS, Harris RB, Dean M, Ali IU. hOGG1 genotype, green tea, and oxidative DNA damage among heavy smokers. Evidence-Based Integrative Medicine. 2004;1:245–51.
28. Hakim IA, Harris RB, Brown S, Chow H-HS, Wiseman S, Agarwal S, Talbot W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr. 2003;133:3303S–9S.
29. Kasai H. Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. Free Radic Biol Med. 2002;33:450–6.[Medline]
30. Yoshida R, Ogawa Y, Kasai H. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. Cancer Epidemiol Biomarkers Prev. 2002;11:1076–81.
31. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43:305–10.[Medline]
32. Kivits GAA, van der Sman FJP, Tijburg LBM. Analysis of catechins from green and black tea in humans. A specific and sensitive colorimetric assay of total catechins in biological fluids. Int J Food Sci Nutr. 1997;48:387–92.
33. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yang CS. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev. 1995;4:393–9.[Abstract]
34. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996;236:184–6.[Medline]
35. Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409–12.
36. Santella RM. DNA damage as an intermediate biomarker in intervention studies. [Review] Proc Soc Exp Biol Med. 1997;216:166–71.
37. Bouchardy C, Benhamou S, Jourenkova N, Dayer P, Hirvonen A. Metabolic genetic polymorphisms and susceptibility to lung cancer. [Review] Lung Cancer. 2001;32:109–12.
38. Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis. 1994;15:415–8.
39. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 1993;14:1479–81.
40. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, Vainio H, Husgafvel-Pursiainen K, Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer. 1998;77:516–21.[Medline]
41. Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 1993;53:1004–11.
42. Alexandrie AK, Sundberg M, Seidegard J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994;15:1785–90.
43. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst. 1995;87:1246–53.
44. Inoue M, Osaki T, Noguchi M, Hirohashi S, Yasumoto K, Kasai H. Lung cancer patients have increased 8-hydroxydeoxyguanosine levels in peripheral lung tissue DNA. Jpn J Cancer Res. 1998;89:691–5.
45. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxy-guanosine, in a central site of the human lung. Carcinogenesis. 1997;18:1763–6.
46. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst. 2005;97:567–76.
47. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature. Mol Carcinog. 2005;42:127–41.[Medline]
48. Hardie LJ, Briggs JA, Davidson LA, Allan JM, King RF, Williams GI, Wild CP. The effect of hOGG1 and gluthathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis. 2000;21:167–72.
49. Halliwell B. Oxidative stress, nutrition and health, experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996;25:57–74.[Medline]
50. Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr. 2000;72:1082–7.
51. Arab L, Blumberg JB. Introduction to the Proceedings of the Fourth International Scientific Symposium on Tea and Human Health. J Nutr. 2008;138:1526S–8S.
52. Henning SM, Choo JJ, Heber D. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J Nutr. 2008;138:1529S–34S.
53. Auger C, Mullen W, Hara Y, Crozier A. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J Nutr. 2008;138:1535S–42S.
54. Song WO, Chun OK. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr. 2008;138:1543S–7S.
55. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138:1548S–53S.
56. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, Ferri L, Desideri G. Tea, flavonoids, and NO-mediated vascular reactivity. J Nutr. 2008;138:1554S–60S.
57. Arts ICW. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr. 2008;138:1561S–6S.
58. Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-Theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr. 2008;138:1572S–7S.
59. Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MBH. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. 2008;138:1578S–83S.
60. Stote KS, Baer DJ. Tea consumption may improve biomarkers of insulin sensitivity and risk factors for diabetes. J Nutr. 2008;138:1584S–8S.
This article has been cited by other articles:
![]() |
L. Arab and J. B. Blumberg Proceedings of the Fourth International Scientific Symposium on Tea and Human Health. September 18, 2007. Washington, DC, USA. J. Nutr., August 1, 2008; 138(8): 1526S - 1588S. [Full Text] [PDF] |
||||
![]() |
S. M. Henning, J. J. Choo, and D. Heber Nongallated Compared with Gallated Flavan-3-ols in Green and Black Tea Are More Bioavailable J. Nutr., August 1, 2008; 138(8): 1529S - 1534S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Auger, W. Mullen, Y. Hara, and A. Crozier Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy J. Nutr., August 1, 2008; 138(8): 1535S - 1542S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O. Song and O. K. Chun Tea Is the Major Source of Flavan-3-ol and Flavonol in the U.S. Diet J. Nutr., August 1, 2008; 138(8): 1543S - 1547S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuriyama The Relation between Green Tea Consumption and Cardiovascular Disease as Evidenced by Epidemiological Studies J. Nutr., August 1, 2008; 138(8): 1548S - 1553S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grassi, A. Aggio, L. Onori, G. Croce, S. Tiberti, C. Ferri, L. Ferri, and G. Desideri Tea, Flavonoids, and Nitric Oxide-Mediated Vascular Reactivity J. Nutr., August 1, 2008; 138(8): 1554S - 1560S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. W. Arts A Review of the Epidemiological Evidence on Tea, Flavonoids, and Lung Cancer J. Nutr., August 1, 2008; 138(8): 1561S - 1566S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kelly, M. Gomez-Ramirez, J. L. Montesi, and J. J. Foxe L-Theanine and Caffeine in Combination Affect Human Cognition as Evidenced by Oscillatory alpha-Band Activity and Attention Task Performance J. Nutr., August 1, 2008; 138(8): 1572S - 1577S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mandel, T. Amit, L. Kalfon, L. Reznichenko, and M. B. H. Youdim Targeting Multiple Neurodegenerative Diseases Etiologies with Multimodal-Acting Green Tea Catechins J. Nutr., August 1, 2008; 138(8): 1578S - 1583S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Stote and D. J. Baer Tea Consumption May Improve Biomarkers of Insulin Sensitivity and Risk Factors for Diabetes J. Nutr., August 1, 2008; 138(8): 1584S - 1588S. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||